{
    "nctId": "NCT01351376",
    "briefTitle": "LLLT Combined With CDT in Breast Cancer-Related Lymphedema",
    "officialTitle": "The Effectiveness of Low Level Laser Therapy (LLLT)Combined With Complex Decongestive Therapy (CDT) in the Treatment of Breast Cancer-Related Lymphedema: A Double-Blind, Randomized, Placebo-Controlled Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "Arm Volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* unilateral breast cancer with ipsilateral lumpectomy or mastectomy and lymph node dissection (sentinel biopsy or axillary dissection)\n* stage II or III unilateral secondary upper extremity lymphedema (as defined by the International Society of Lymphology)\n* girth \u2265 2 cm circumferential difference and/or volume \u2265 200 mL compared to the uninvolved upper extremity at any 4 cm segment\n* able to commit to a long term follow-up schedule\n\nExclusion Criteria:\n\n* active cancer/metastatic cancer\n* currently receiving or have plans for adjuvant radiation or chemotherapy\n* pregnant\n* presence of other extremity lymphedema (primary or secondary)\n* pacemaker\n* artificial joints in the upper quadrants\n* renal failure\n* arterial insufficiency\n* congestive heart failure\n* chronic inflammatory conditions\n* history of deep vein thrombosis (DVT) in the lymphedematous upper extremity\n* previous treatment with Low Level Laser (regardless of indication)\n* medication(s) known to affect body fluid balance\n* body mass index (BMI) \\> 40 (morbid obesity)",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}